REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 161 filers reported holding REATA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $11,126,997 | -1.8% | 109,131 | -12.4% | 0.03% | -12.5% |
Q1 2023 | $11,326,814 | +105.0% | 124,580 | -14.3% | 0.03% | +88.2% |
Q4 2022 | $5,525,418 | +357.0% | 145,444 | +202.3% | 0.02% | +325.0% |
Q3 2022 | $1,209,000 | -55.1% | 48,115 | -52.8% | 0.00% | -33.3% |
Q4 2021 | $2,690,000 | -63.9% | 102,002 | +97.4% | 0.01% | -90.2% |
Q1 2020 | $7,460,000 | +261.4% | 51,682 | +114.0% | 0.06% | +771.4% |
Q1 2019 | $2,064,000 | – | 24,147 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |